Your Article Summary
See Latest ArticlesPatient-reported outcomes in a phase III, randomized study of sunitinib versus interferon- as first-line systemic therapy for patients with metastatic renal cell carcinoma in a European population
Annals of Oncology, 06/24/09
Castellano D et al. - Results consistently showed that patients in sunitinib group experienced statistically significantly milder kidney-related symptoms, better cancer-specific HRQoL and general health status (in social utility scores) during the study period as measured by these patient-reported outcome end points. No statistical differences between groups were found on the FACT-G physical well-being subscale or the EQ-5D VAS values.
Related Articles
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 83%
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 83%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 83%
Prognostic factors for renal cell carcinoma: Trakya University experience from Turkey
European Journal of Cancer Care, 10/22/09
Relevance Score: 83%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 83%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Renal cell carcinoma with caval involvement: Contemporary strategies of surgical treatment
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells
Urologic Oncology: Seminars and Original Investigations, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of pazopanib in patients with metastatic renal cell carcinoma
Journal of Clinical Oncology, 12/18/09
Renal Function Outcomes in Kidney Transplant Recipients After Conversion to Everolimus-Based Immunosuppression Regimen with CNI Reduction or Elimination
Transplantation Proceedings, 12/18/09
Low-Dose Dopamine in Kidney Transplantation
Transplantation Proceedings, 12/18/09